Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04584255 |
|---|---|
| Brief Title: | Niraparib + Dostarlimab In BRCA Mutated Breast Cancer |
| First Submitted : | October 8, 2020 |
| First Submitted that Met QC Criteria : | October 8, 2020 |
| First Posted : | October 12, 2020 |
| Last Update Submitted that Met QC Criteria : | October 13, 2023 |
| Last Update Posted : | October 17, 2023 |